GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » EBITDA Margin %

Devyser Diagnostics AB (OSTO:DVYSR) EBITDA Margin % : -24.64% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Devyser Diagnostics AB's EBITDA for the three months ended in Mar. 2025 was kr-13.5 Mil. Devyser Diagnostics AB's Revenue for the three months ended in Mar. 2025 was kr54.8 Mil. Therefore, Devyser Diagnostics AB's EBITDA margin for the quarter that ended in Mar. 2025 was -24.64%.


Devyser Diagnostics AB EBITDA Margin % Historical Data

The historical data trend for Devyser Diagnostics AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB EBITDA Margin % Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial 2.47 -15.98 -34.52 -23.92 -12.17

Devyser Diagnostics AB Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.71 -28.01 -32.03 12.46 -24.64

Competitive Comparison of Devyser Diagnostics AB's EBITDA Margin %

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devyser Diagnostics AB's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's EBITDA Margin % falls into.


;
;

Devyser Diagnostics AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Devyser Diagnostics AB's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-26.4/216.9
=-12.17 %

Devyser Diagnostics AB's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-13.5/54.8
=-24.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Devyser Diagnostics AB  (OSTO:DVYSR) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Devyser Diagnostics AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Devyser Diagnostics AB Business Description

Traded in Other Exchanges
Address
Instrumentvagen 19, Hagersten, SWE, 126 53
Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines